Clinical Trial Detail

NCT ID NCT02632071
Title Phase I of ACY-1215 + Nab-paclitaxel in Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kevin Kalinsky
Indications

breast adenocarcinoma

Therapies

Nab-paclitaxel + Ricolinostat

Age Groups: adult

No variant requirements are available.